On Friday, worried investors of Maruti Suzuki took the extraordinary step of bypassing the management and spoke directly to the representative of the workers'union.
The company is going through a crippling strike, which has taken the stock price to a 52-week low.
A few days ago, minority investors forced Crompton Greaves to give a commitment to fund managers that it was in the process of selling a Rs 270 crore (Rs 2.7 billion) jet to an unlisted group company.
The jet was bought in a year when Crompton reported disappointing profit numbers.
There's more: Last week, LIC, the country's largest institutional investor, found itself at the receiving end of Voices of Tobacco Victims, an NGO working for cancer patients, which raised questions over the ethics and irony of the state-owned life insurance company investing up to Rs 3,500 crore (Rs 35 billion) in various tobacco companies.
And Vedanta's Anil Aggarwal has had several run-ins with his investors, dating back to 2002.
When he tried to delist Sterlite from the Indian exchanges and started sending cheques to retail investors for the value of their shares, many challenged his move, forcing him to withdraw the exercise.
Years later, investors hammered his stocks when he tried to restructure his group by merging Sterlite Industries with group firms.
Again, he had to withdraw.
Shareholder activism in India, which was enjoying its infancy for several decades, seems to be growing from baby steps to youthful strides.
Amit Tandon, former MD, Fitch Ratings, agrees, "Surely, the level of awareness has increased."
Tandon himself is involved in one such initiative with former Gujarat Ambuja chief Anil Singhvi.
Called Institutional Investors Advisory Services, the firm, among other things, goes through AGM and EGM resolutions of companies and writes reports to aid investors exercise their votes in an informed manner.
Tandon is not sure if the Maruti investors' action can be strictly called 'activism', but cites recent instances like the dumping of Piramal Healthcare by institutional investors.
In the quarter ended June 30, the open-ended equity schemes of some of India's top fund houses had exited Piramal Healthcare.
While they did not give any official reason for the move, it is an open secret that it was in disapproval of the company's unwillingness to share the fortune created by the sale of key assets to Abbott in a $3.7 billion deal last year.
Such activism often hasn't succeeded.
For example, IIAS had attacked Hindalco's governance practices at its AGM, opposing moves to reappoint two independent directors who had been on the board for 15 to 30 years and therefore defeated the very purpose of their independence.
IIAS also targeted the company's auditors who had been serving for half a century. Both the recommendations were, however, shot down at the AGM.
Rakesh Arora, managing director, Macquaire, a foreign institutional investor, says investors can do only so much with small holdings.
"While increased activism is good, it is barely there in India because most companies are entrepreneur driven. Internationally, institutions have a high shareholding in companies.
Even the managements are professional. Therefore, they can exert more pressure on companies to deliver."
Unlike in the West, Indian promoters typically control most of the voting rights in listed companies, which they often run like mom-and-pop stores.
According to a report by the Achuthan committee on takeover regulations, the mean of total promoter holdings of 4,054 listed companies was 48.9 per cent.
It was higher at 55.2 per cent for 459 large companies with a market cap of over Rs 10,000 crore (Rs 100 billion).
The Companies Act, 1956 requires a minimum of one share more than 25